FF
IONS icon

Friedenthal Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Friedenthal Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,115
Closed -$1.04M – 276
2025
Q4 		$1.04M Buy
+13,115
New +$988K 0.53% 38
2024
Q1 		– Sell
-14,225
Closed -$720K – 256
2023
Q4 		$720K Buy
+14,225
New +$681K 0.47% 67

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Friedenthal Financial's IONS Position: Q1 2026 in Review

Friedenthal Financial sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 13,115 shares — an estimated $1.04M sold.

Friedenthal Financial first reported a position in IONS in Q4 2023 and held it in 2 quarters. The position peaked at $1.04M in Q4 2025. 496 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Friedenthal Financial reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Friedenthal Financial sold 13,115 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.04M.
  • Friedenthal Financial first reported a position in Ionis Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Friedenthal Financial's Ionis Pharmaceuticals position peaked at $1.04M in Q4 2025.
  • 496 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Friedenthal Financial's 13F filing for Q1 2026, filed 20 Apr 2026.